Related Experiment Video
Updated: Feb 4, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
[Meningococcal infections in Switzerland : changes in epidemiology, clinical manifestations and prophylaxis]
Stéphane Emonet1,2, Rita Born3, Jacques Schrenzel2,4
1Service des maladies infectieuses, Institut central des hôpitaux, Hôpital du Valais, Av. du Grand-Champsec 86, 1950 Sion.
Abstract:
In the last decade, the epidemiology of meningococcal infections in Switzerland and Europe has changed. The prevalence of Y and W serogroups augmented, with more atypical clinical manifestations such as pharyngitis, pneumonia and arthritis. A hypervirulent clonal serogroup W strain of Neisseria meningitidis has emerged in Europe and Switzerland, with a noticeable potential for epidemics as evidenced by its clonality. In this context, vaccinal recommendations for risk groups have and will continue to evolve towards the use of novel conjugated vaccines.
Insights
Meningococcal infection patterns have shifted in Europe and Switzerland, with increased prevalence of serogroups Y and W. A hypervirulent Neisseria meningitidis strain necessitates updated vaccination strategies for at-risk populations.
Area of Science:
- Epidemiology
- Infectious Diseases
- Microbiology
Background:
- Meningococcal infections pose a significant public health challenge.
- Recent epidemiological shifts in Europe and Switzerland indicate changing disease patterns.
Purpose of the Study:
- To analyze the evolving epidemiology of meningococcal infections.
- To highlight the emergence of specific serogroups and strains.
- To inform updated vaccination recommendations.
Main Methods:
- Epidemiological surveillance data analysis.
- Strain characterization and clonal analysis.
- Review of clinical manifestations and disease trends.
Main Results:
- Increased prevalence of Neisseria meningitidis serogroups Y and W observed.
- Emergence of a hypervirulent, clonal serogroup W strain identified.
- Atypical clinical presentations including pharyngitis, pneumonia, and arthritis are more common.
Conclusions:
- The epidemiology of meningococcal disease is changing, driven by serogroup shifts and a hypervirulent W strain.
- Updated vaccinal recommendations are crucial for managing emerging risks.
- Conjugated vaccines are key to addressing these evolving threats.
Related Concept Videos
Acute Pancreatitis II: Clinical Manifestations and Management
Angina III: Clinical Manifestations and Assessment
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Chronic Kidney Disease II: Clinical Manifestations
Esophageal Perforation-II: Clinical Manifestations and Management
Clinical Manifestations:

